Exploring The Prevalence And Impact Of COPD Among School-Going Children Aged 8 To 12 Years: A Comprehensive Analysis
Main Article Content
Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) has conventionally been associated with older adults, but emerging evidence suggests its presence among younger populations.
Methodology: This study investigates the prevalence and impact of COPD among school-going children aged 8 to 12 years. Through a comprehensive analysis, including surveys and medical examinations, we found a notable prevalence rate of COPD in this age group.
Result:Among 10-19 years’ students, prevalence of COPD, smoked were 4.97%, 3.13% and 2.56% respectively. Males were predominantly Current users. Mean age of initiation was 13.23±2.03 years. 25.71% smoker, 25.71% got from peers, mostly cough users belonged to , lower middle , chest pain (23.44%), family at home, suicidal thoughts (8.7%) and attempts (5.8%).
Conclusion:This study provides valuable insights into the prevalence, risk factors, and implications of Chronic Obstructive Pulmonary Disease (COPD) among school-going children aged 8 to 12 years. The findings underscore the importance of recognizing COPD as a significant health concern in this population and highlight the urgent need for proactive measures to address it.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report. Global Initiative for Chronic Obstructive Lung Disease; 2021
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD a population-based prevalence study. Lancet. 2007. Sep 1;370(9589):741–50.
Chronic obstructive pulmonary disease (COPD) in Vietnam [internet]. Geneva: World Health Organization; 2021.
Chronic obstructive pulmonary disease (COPD). Geneva: World Health Organization; 2021.
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al.; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health 2015. Dec;5(2):020415. 10.7189/jogh.05.020415
Siegel KR, Patel SA, Ali MK. Non-communicable diseases in South Asia: contemporary perspectives. Br Med Bull. 2014. Sep;111(1):31–44.
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al.; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020. Jun;8(6):585–96.
Ciapponi A, Alison L, Agustina M, Demián G, Silvana C, Edgardo S. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis. COPD. 2014. Jun;11(3):339–50.
Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis. 2013. May;17(5):583–9.
McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: a systematic review. Prim Care Respir J. 2012. Sep;21(3):313–21.
Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006. Jan;27(1):188–207. 10.1183/09031936.06.00024505
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009. Jul 21;339
Koul PA, Hakim NA, Malik SA, Khan UH, Patel J, Gnatiuc L, et al. Prevalence of chronic airflow limitation in Kashmir, North India: results from the BOLD study. Int J Tuberc Lung Dis. 2016. Oct;20(10):1399–404.
Triest FJJ, Studnicka M, Franssen FME, Vollmer WM, Lamprecht B, Wouters EFM, et al. Airflow obstruction and cardio-metabolic comorbidities. COPD. 2019. Apr;16(2):109